trending Market Intelligence /marketintelligence/en/news-insights/trending/mm7czH-kDc45D8XUnXATBg2 content esgSubNav
In This List

Ionis CEO to become executive chairman in 2020

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Ionis CEO to become executive chairman in 2020

Ionis Pharmaceuticals Inc. said founder and CEO Stanley Crooke will transition to executive chairman of the company's board of directors, effective January 2020.

Brett Monia, who has been COO for the previous year and a founding member of Carlsbad, Calif.-based Ionis, will take over from Crooke as CEO.

Crooke will continue to be in charge of board affairs and will provide strategic advice, as well as participate in the scientific activities of the company.

Ionis develops RNA-targeted therapies for genetic diseases such as spinal muscular atrophy, transthyretin amyloidosis and familial chylomicronemia syndrome.